TGDLF yields 6.21% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, TGDLF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TGDLF + JNJ for your $10,000?
Tongdao Liepin Group, an investment holding company, provides talent acquisition services in the People's Republic of China. The company operates Liepin, a talent acquisition platform, which offers online recruitment services for headhunters, business users, and individual users. It also operates Duomian, a video-based talent platform that allows job descriptions of business users and self-introductions of individual users in short video format; Xunhou, a staffing platform, which provides staffing SaaS solutions, such as human resource outsourcing, recruitment outsourcing, personnel agency, and campus recruitment; Lebanban, a training and assessment platform that offers employee learning and development solutions comprising training courses and employee performance evaluation; and Wenjuanxing, a survey SaaS platform, which provides data collection, storage, and analysis, as well as offers Liepin Campus, a campus recruitment solution, including online/offline campus presentation, employer branding, etc. In addition, it offers online survey and education services. The company was formerly known as Wise Talent Information Technology Co., Ltd and changed its name to Tongdao Liepin Group in July 2020. Tongdao Liepin Group was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China.
Full TGDLF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.